Cosmo Pharmaceuticals N.V. (LON:0RGI)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 7, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,615	901	763	900	895	1,018
Market Cap Growth	85.26%	18.10%	-15.23%	0.57%	-12.08%	16.39%
Enterprise Value	1,513	795	727	864	864	956
Last Close Price	99.27	54.21	44.95	50.96	47.90	63.34
PE Ratio	31.40	8.18	-	58.91	49.16	-
PS Ratio	10.34	4.08	9.48	9.94	16.37	18.64
PB Ratio	4.03	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	17.59	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	27.80	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	25.63	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	9.54	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	21.44	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	25.31	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	26.05	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.01	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.03	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.04	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.29	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.64	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.59	3.39	3.22	1.45	11.77	11.06
Current Ratio	3.84	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	12.34%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	6.88%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	8.80%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	12.20%	24.90%	-0.40%	5.00%	1.40%	0.30%
Earnings Yield	3.18%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	3.60%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	1.64%	3.13%	3.86%	1.83%	1.67%	-
Payout Ratio	94.36%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.65%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	-0.01%	1.19%	5.81%	4.66%	-15.15%	1.11%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.